Queens, NY – New York State Assemblywoman Stacey Pheffer Amato’s Office celebrated the signing of A.1707 which requires manufacturers of prescription drugs to present notification of any proposed cost increase. The law is set to take effect in the coming months and Pheffer Amato was the prime co-sponsor of this bill.

Bill A.1707 addresses the ongoing increase for prescription drugs throughout the pharmaceutical industry by requiring manufacturers to provide at least 60-day notice of their intent to raise prescription drug costs. In addition, they are required to provide a rationale to the New York State Department of Financial Services.

“My constituents deserve to know if there is a cost increase of their medication. By doing this we ensure that the consumers are given crucial notice and are able to take any necessary steps prior to the increase. We’re demanding transparency from big pharma,” said Pheffer Amato. The bill was supported by several groups including AARP.